l.osei
TL2 · Cork
Contributes reviews on supplier material. Based in Cork.
Joined 25 February 2025 · last posted 9d
86 posts, newest first. Showing up to 150.
-
What the GIP component of tirzepatide is thought to contribute, and how confident we can… Replied, post #11 · Compounds › Tirzepatide · 19 Jul 2026 · 5 likes Storage and stability: published data on licensed tirzepatide formulations exists and is worth reading directly rather than through summarised claims. Reconstituted…
-
Blinding yourself: practical methods and their limits Replied, post #42 · Research Methods › N-of-1 designs · 13 Jul 2026 · 12 likes I read post #41 twice before replying, because I had assumed the opposite. Trying to state the blinding yourself position in a way that someone who disagrees would…
-
What I would want from a home test that does not exist yet Replied, post #33 · Analytics › Home & field testing · 10 Jul 2026 · 0 likes Where a home observation and an independent result disagree, the independent one is measuring something more specific. That does not make the home observation useless —…
-
Seven-day rolling means and why weekly readings mislead Replied, post #6 · Outcomes › Progress reports · 10 Jul 2026 · 0 likes Confirming post #5 from a second method, which matters more than confirming it from a second person. The best progress reports here read as records rather than as…
-
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #50 · Compounds › Retatrutide · 10 Jul 2026 · 0 likes On analysis: a chromatographic purity figure for an investigational compound is harder to interpret than for a well-characterised one, because there is no reference…
-
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #32 · Evidence › Journal club · 7 Jul 2026 · 0 likes This follows post #29 rather than contradicting it. An observation about SUSTAIN 6 that I cannot explain and am posting anyway, on the principle that unexplained…
-
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #97 · Safety › Contraindications · 3 Jul 2026 · 33 likes Answering the question post #93 raises rather than the one it answers. Allergy to the specific compound: true allergy is rare but possible. Any prior allergic reaction…
-
Tracking a shortage from primary sources rather than rumour Replied, post #82 · Access › Shortages · 3 Jul 2026 · 0 likes Regional differences during a shortage are large, and a supply position in one country says nothing about another. Worth checking against a second source before it gets…
-
Follow-up: Signs of dehydration worth acting on Replied, post #12 · Safety › Adverse events · 3 Jul 2026 · 0 likes The reason Signs of dehydration worth acting keeps being re-asked is that the answer is conditional and people quote it without the condition. It is not that the answer…
-
Revisiting: Can a home kit substitute for a laboratory report? A careful no Replied, post #39 · Analytics › Home & field testing · 23 Jun 2026 · 1 like Ultraviolet absorbance at 280 nanometres estimates concentration for peptides containing aromatic residues and gives nothing for peptides that do not. Knowing which…
-
Ultrasound and skinfolds: operator dependence in practice Replied, post #21 · Outcomes › Body composition · 18 Jun 2026 · 0 likes Post #19 and I disagree about the size of the effect, not about the direction. Bone mineral density changes with substantial weight loss are measurable and slow, and…
-
Follow-up: Reconciling a label claim with a content assay Replied, post #24 · Analytics › COA interpretation · 7 Jun 2026 · 30 likes Reconciling a label claim has been discussed here with more heat than it deserves, mostly because two definitions have been in play the whole time.
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #118 · Compounds › Tirzepatide · 2 Jun 2026 · 18 likes The five maintenance doses in the tirzepatide programme give a genuine dose-response curve, which is unusual. Most trials in this space compare one or two doses against…
-
Follow-up: Sleep quality changes during weight loss Replied, post #15 · Wellbeing › Sleep · 3 May 2026 · 30 likes I read post #11 twice before replying, because I had assumed the opposite. Sleep hygiene: basics (cool dark room, consistent sleep time, no screens before bed) matter…
-
What a good consultation looks like from the other side Replied, post #33 · Clinical › Prescriber conversations · 19 Apr 2026 · 0 likes Marking my uncertainty on good consultation explicitly. I am confident about the direction, much less confident about the size, and not confident at all that it…
-
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #39 · Devices › Syringes & needles · 18 Apr 2026 · 17 likes Post #37 describes the usual case. This is about the unusual one. 0.3 ml versus 0.5 ml has a well-known answer and a correct answer, and the interesting work is…
-
Review: a draft on reconstitution arithmetic, with objections — one year on Replied, post #2 · Documentation › Doc review · 16 Apr 2026 · 10 likes Check the arithmetic in every worked example by hand. A wrong worked example is worse than no example and survives longer.
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #125 · Pharmacology › Pharmacokinetics · 6 Apr 2026 · 12 likes Post #123 is the version of this I will quote in future. One addition. Subcutaneous absorption is the rate-limiting step for most of these compounds, which is why the…
-
What TRIUMPH is designed to answer, and why we should not pre-empt it — does this still… Replied, post #11 · Compounds › Retatrutide · 31 Mar 2026 · 0 likes Genuine question rather than a rhetorical one: has anyone here actually observed TRIUMPH, as opposed to read about it? The thread is long and I cannot tell.
-
Pregnancy and pregnancy planning: contraindication and washout Replied, post #77 · Clinical › Special populations · 18 Mar 2026 · 9 likes Post #76 put the caveat in the right place and I want to underline it. Being outside the studied population does not mean a treatment is unsafe. It means the usual…
-
A site rotation scheme that is easy enough to actually follow Replied, post #22 · Practice › Administration · 18 Mar 2026 · 8 likes On post #18 — agreed on the reasoning, with one qualification. If you have to inject at a different time of day than usual, that is a much smaller perturbation than it…
-
Reused chromatograms across lots: how to spot it Replied, post #24 · Analytics › COA interpretation · 4 Mar 2026 · 0 likes Post #23 describes the usual case. This is about the unusual one. One caution on reused chromatograms across lots: everything above assumes the underlying documentation…
-
Non-inferiority margins: how they are chosen and how they are abused Replied, post #47 · Evidence › Trials · 15 Feb 2026 · 0 likes Building on post #45 rather than restating it. An observation about non-inferiority margins that I cannot explain and am posting anyway, on the principle that…
-
MHRA statements, read directly Replied, post #82 · Regional › UK & Ireland · 4 Feb 2026 · 8 likes Good question, well framed, and I would like to see it answered properly.
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #31 · Pharmacology › Pharmacokinetics · 2 Feb 2026 · 31 likes I changed my mind about Washout after someone here asked me for the source and I could not produce one. That is worth saying out loud because it is the ordinary way it…
-
Reading an interaction checker output critically Replied, post #101 · Practice › Interactions · 25 Jan 2026 · 0 likes Nothing here is medical advice and an interaction question is one where the cost of a wrong forum answer is genuinely high. Ask the prescriber or the pharmacist.
-
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #7 · Clinical › Special populations · 20 Jan 2026 · 26 likes Being outside the studied population does not mean a treatment is unsafe. It means the usual evidence is not available and the reasoning has to be explicit. Take it as…
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #68 · Clinical › Special populations · 5 Jan 2026 · 12 likes Narrowing post #67, because the general version has more than one answer. The useful distinction on older adults is between what was measured and what was inferred from…
-
Cost per delivered dose, which is the number that matters Replied, post #35 · Access › Pricing · 1 Jan 2026 · 1 like Confirming post #34 from a second method, which matters more than confirming it from a second person. Where somebody posts a comparison, the useful version states the…
-
Warfarin and altered intake: the monitoring argument — the long version Replied, post #76 · Practice › Interactions · 25 Dec 2025 · 12 likes Two things can be true about Warfarin and altered intake at once: the mechanism is plausible and the evidence for the size of the effect is thin. Most of the argument…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 — does this still hold? Replied, post #21 · Compounds › Cagrilintide & amylin analogues · 25 Dec 2025 · 4 likes Reading back through the Amylin analogue mechanism threads from last year, the same three questions come up every time and only one of them has ever been answered…
-
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #47 · Compounds › Semaglutide · 22 Dec 2025 · 23 likes Answering the question post #45 raises rather than the one it answers. Albumin binding is not a unique structural feature and nothing in the class lacks it, but the…
-
Revisiting: Language barriers in accessing a prescription abroad Replied, post #18 · Access › International · 19 Dec 2025 · 28 likes Taking post #17 at face value and following it one step further. Where a jurisdiction has published guidance for clinicians, that document usually answers the practical…
-
Reused chromatograms across lots: how to spot it — what changed since Replied, post #6 · Analytics › COA interpretation · 17 Dec 2025 · 1 like The distinction between release testing and characterisation is one industrial documents make and retail ones usually do not. It is the difference between "we tested…
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #26 · Pharmacology › Pharmacokinetics · 26 Nov 2025 · 1 like Half-life: semaglutide ≈ 165–184 hours (about a week). Tirzepatide ≈ 5 days. Liraglutide ≈ 13 hours. The half-life determines how much accumulation happens at steady…
-
Lurking for two months before posting: was that the right call? Replied, post #50 · Start Here › Welcome · 19 Nov 2025 · 4 likes The compound and evidence pages are updated regularly and they are worth reading when you are new. They answer the meta questions like "do we have data on this" and…
-
Pharmaceutical compounding rules, summarised from primary sources — a second dataset Replied, post #32 · Sourcing › Regulatory · 15 Nov 2025 · 0 likes Where a claim about legality is made here, the useful follow-up is which instrument it rests on. Most such claims turn out to rest on a forum post. One case, stated as…
-
Pen dose counters: what a click does and does not guarantee Replied, post #30 · Devices › Pens & autoinjectors · 14 Nov 2025 · 4 likes Needle installation: some pens require a fresh needle for each injection; others have a single needle that stays attached. Check the design of your pen.
-
The anatomy of a question that gets answered within an hour — the long version Replied, post #78 · Start Here › How to Ask · 10 Nov 2025 · 6 likes If the answer you got does not fit your case, say which part does not fit rather than restating the question. Otherwise the next reply is the same as the last one.…
-
Where to report an adverse event officially, by region — a second dataset Replied, post #109 · Safety › Adverse events · 9 Nov 2025 · 0 likes Where a member describes something concerning, escalating the thread rather than continuing it is a moderation practice rather than a dismissal. The confident version…
-
Amylin receptor signalling and satiety Replied, post #26 · Pharmacology › Receptor biology · 2 Nov 2025 · 12 likes Post #25 answers the question as asked. The question underneath it is different. Having read the whole amylin receptor signalling and satiety thread before replying:…
-
Follow-up: What a seizure notice actually says Replied, post #37 · Sourcing › Logistics · 27 Oct 2025 · 6 likes Coming back to post #35, because the follow-up matters more than the original answer. Document outcomes rather than forecasting them. A forecast in this category reads…
-
Where impurities in solid-phase peptide synthesis come from Replied, post #15 · Analytics › Impurities & related substances · 23 Oct 2025 · 29 likes Related substances: compounds chemically related to the target peptide but not the target peptide itself. The standard method separates them and reports them as area…
-
What a purity-only report leaves out Replied, post #55 · Sourcing › Independent verification · 21 Oct 2025 · 3 likes Adding a small correction to the purity-only summary above rather than a disagreement with it. The substance holds; one of the figures is out by a factor that matters.
-
Thyroid function tests during substantial weight change Replied, post #92 · Clinical › Bloodwork · 11 Oct 2025 · 1 like Post #89 is right about the mechanism and I think understates the practical bit. Lipid changes during substantial weight loss are expected and their trajectory is not…
-
Coming back to: Over-dilution: when your dose falls below one readable graduation Replied, post #64 · Practice › Reconstitution · 5 Oct 2025 · 0 likes Over-dilution has a well-known answer and a correct answer, and the interesting work is establishing that they are the same. Nobody has done that here yet.
-
Documentation that appears only after payment Replied, post #37 · Sourcing › Red flags · 30 Sep 2025 · 5 likes Post #36 is right about the mechanism and I think understates the practical bit. The question underneath documentation is usually "how would I tell?" rather than "what…
-
Coming back to: Resolution and tailing factor: real acceptance criteria Replied, post #84 · Analytics › HPLC & UHPLC · 26 Sep 2025 · 14 likes Posting my Resolution and tailing factor numbers with the method attached so they can be discounted properly. Uncontrolled, unblinded, and collected by someone who…
-
Reporting a disappointing outcome, and why it belongs here Replied, post #29 · Outcomes › Progress reports · 20 Sep 2025 · 0 likes This settles it for me, at least until somebody posts a reason it should not.
-
Coming back to: Resolution and tailing factor: real acceptance criteria Replied, post #65 · Analytics › HPLC & UHPLC · 10 Sep 2025 · 0 likes Change the wavelength and the proportions change even though the sample has not. That is the reason the wavelength has to be on the document for the number to mean…
-
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #92 · Evidence › Journal club · 10 Sep 2025 · 0 likes Taking post #89 at face value and following it one step further. People arriving without having read it should be welcome and should say so, because a question from…
-
Reading a rodent study on a secretagogue without over-extrapolating Replied, post #45 · Compounds › Secretagogues & GH axis · 8 Sep 2025 · 5 likes That is the distinction I keep failing to hold on to. Written down now.
-
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #71 · Evidence › Journal club · 3 Sep 2025 · 4 likes Sessions on negative or null results are consistently the most instructive and the hardest to get anyone to attend. I am confident about the direction and much less…
-
A ten-fold dose error caught before injection Replied, post #76 · Devices › Syringes & needles · 4 Aug 2025 · 27 likes I read post #72 twice before replying, because I had assumed the opposite. Drawing air into the vial before withdrawing liquid equalises the pressure and makes the draw…
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #97 · Practice › Storage & stability · 27 Jul 2025 · 1 like Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather than to filter and proceed. I have deliberately not rounded that,…
-
What I would record differently if I started again — the long version Replied, post #5 · Outcomes › Progress reports · 23 Jul 2025 · 28 likes Everything in the opening post holds. The case it does not cover is the one I have. Self-reported intake is optimistic in a consistent direction, and saying so in your…
-
Temperature loggers worth the money Replied, post #10 · Devices › Cold chain · 18 Jul 2025 · 15 likes Suppliers that reship after a documented excursion without argument are doing something commercially costly, and it is worth recording when they do. Worth one more…
-
Coming back to: Resolution and tailing factor: real acceptance criteria Replied, post #4 · Analytics › HPLC & UHPLC · 7 Jul 2025 · 3 likes The practical version of Resolution and tailing factor is three sentences long. The rigorous version is three pages and reaches the same conclusion with the conditions…
-
Random versus fixed effects: choosing rather than defaulting Replied, post #10 · Evidence › Meta-analyses · 24 Jun 2025 · 0 likes The I-squared statistic describes the proportion of variability not attributable to chance and is frequently read as a threshold. It is a description rather than a test.
-
Repeatability versus intermediate precision Replied, post #51 · Analytics › Method validation · 24 Jun 2025 · 4 likes The limit of quantitation determines what the impurity table can honestly contain. Peaks below it can be reported as detected and cannot be reported as a number.
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #78 · Access › Insurance & coverage · 12 Jun 2025 · 0 likes Where an exception process exists separately from an appeal, they are different routes with different criteria and using the wrong one loses time. The reasoning is more…
-
Follow-up: Tracking intake honestly when appetite is absent Replied, post #45 · Nutrition & Training › Protein & intake · 8 Jun 2025 · 11 likes Post #43 put the caveat in the right place and I want to underline it. Tracking intake was covered in the wiki last year and the page has a review date on it, which is…
-
Needle changes between doses on a reusable pen — does this still hold? Replied, post #4 · Devices › Pens & autoinjectors · 6 Jun 2025 · 27 likes Confirming the opening post from a second method, which matters more than confirming it from a second person. Pen mechanics: most pens are dial-and-inject devices where…
-
An orphaned page with no inbound links Replied, post #44 · Meta › Wiki maintenance · 23 May 2025 · 0 likes This follows post #41 rather than contradicting it. Small methodological point on orphaned page: repeating a measurement is cheap and resolves most of what is being…
-
Validating a calculator against hand arithmetic — what changed since Replied, post #70 · Data & Tools › Calculators · 15 May 2025 · 4 likes That is consistent with mine, for whatever one more account is worth.
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #96 · Evidence › Journal club · 21 Apr 2025 · 18 likes Session format: read the paper before posting. The discussion is much better when everyone has. Start with the estimand and population, then methods, then results, then…
-
Follow-up: What other technical communities get right that we do not Replied, post #68 · Lounge › Off topic · 15 Apr 2025 · 33 likes Fine by me. I had wanted a stronger conclusion and there is not one available.
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — what changed since Replied, post #50 · Practice › Reconstitution · 14 Apr 2025 · 1 like Concentration is total mass divided by total volume, and everything else follows from that. Ten milligrams into two millilitres is five milligrams per millilitre, and…
-
Fibre intake when total intake falls, and the constipation link Replied, post #51 · Nutrition & Training › Protein & intake · 9 Apr 2025 · 5 likes Post #50 answers the question as asked. The question underneath it is different. Leucine and MPS: leucine stimulates muscle protein synthesis at a threshold of roughly…
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #22 · Sourcing › Vendor reports · 15 Mar 2025 · 0 likes Multiple services on one lot: agreement across two independent laboratories is stronger than a high number from one. Our vendor pages deliberately mix services for that…
-
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #67 · Compounds › Semaglutide · 17 Feb 2025 · 16 likes On identity confirmation: a mass close to 4113.6 Da on the intact molecule is consistent with semaglutide and is also consistent with several closely related species.…
-
Escalating every six weeks instead of four: what I observed over eight months — one year… Replied, post #7 · Practice › Dosing & titration · 4 Feb 2025 · 11 likes Adding the measurement that post #6 says would settle it. Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes…
-
Journal club: STEP 4 and what a withdrawal design can prove — one year on Replied, post #29 · Evidence › Journal club · 28 Jan 2025 · 13 likes What I would want before treating STEP 4 as settled: the method, the sample, and whether anyone tried to find the opposite result. Two of the three are usually missing.
-
What changed in 2026, by region Replied, post #89 · Access › International · 20 Jan 2025 · 1 like Confirming post #87 from a second method, which matters more than confirming it from a second person. Summaries lag badly in this area. Where a decision matters, read…
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #4 · Access › International · 18 Jan 2025 · 22 likes Worth separating two things that post #2 runs together. My position on Cross-border purchase within is current rather than settled. I have revised it once already and I…
-
Oxidation and deamidation mass shifts, tabulated Replied, post #30 · Analytics › Mass spectrometry · 3 Jan 2025 · 2 likes Right — I had this wrong and I am glad to have read it before it mattered.
-
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #59 · Compounds › Oral incretins · 27 Dec 2024 · 10 likes Useful. I had the fact and not the reason, which turns out to be the important half.
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #3 · Practice › Reconstitution · 25 Dec 2024 · 21 likes The arithmetic in post #2 is right; the assumption feeding it is the part to check. On 5 mg vial, the part that usually goes wrong is that the question is asked as…
-
About the Wiki requests category Replied, post #5 · Documentation › Wiki requests · 19 Dec 2024 · 13 likes Correction requests: if you spot an error in a maintained page, note it here with the specific correction. The maintainer will review and update if justified. The rule…
-
A promotion I argued against, and why I lost Replied, post #13 · Documentation › Doc review · 25 Nov 2024 · 11 likes Reading back through, this was answered upthread and I missed it. My fault.
-
Follow-up: Recovery when intake is low: what to cut first Replied, post #27 · Nutrition & Training › Resistance training · 17 Nov 2024 · 2 likes Summarising the Recovery thread so far, since it is long and the answer is buried: the first reply has the method, the fourth has the correction to it, and the rest is…
-
Time to steady state after a dose increase Replied, post #57 · Pharmacology › Pharmacokinetics · 4 Nov 2024 · 1 like Steady state is approached in roughly four to five half-lives. For a compound with a week-long half-life that is four to five weeks, which is where the escalation…
-
Second pass at: Food noise reducing and the disorientation that can follow Replied, post #39 · Wellbeing › Mental health · 19 Oct 2024 · 1 like On Food noise I would separate what is worth knowing from what is worth acting on. The first list is long and the second is short, and conflating them is how threads…
-
Blind submission and why it changes minds Replied, post #65 · Sourcing › Independent verification · 19 Sep 2024 · 1 like Worth separating two things that post #64 runs together. Two things can be true about blind submission at once: the mechanism is plausible and the evidence for the size…
-
Pancreatitis history and the risk calculus — a second dataset Replied, post #6 · Safety › Contraindications · 2 Sep 2024 · 5 likes Pancreatitis history was covered in the wiki last year and the page has a review date on it, which is a better starting point than my memory of a thread.
-
Progressive overload when the scale is falling — one year on Replied, post #2 · Nutrition & Training › Resistance training · 23 Aug 2024 · 6 likes Following this. I have the same question and no better information than the first post.